COMPEL · COsts and Mechanisms of Personalised Exercise and Education for chronic Low back pain
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2018-01-08 → 2021-01-07
- EU contribution
- €254,313
- Participants
- 2
- Scheme
- MSCA-IF
Lines connect the coordinator with its partners.
Results in brief
COsts and Mechanisms of Personalised Exercise and Education for chronic Low back pain
Chronic low back pain is the leading cause of disability in Europe and worldwide. The societal costs are enormous, and this economic burden is predicted to increase as the EU population ages. Exercise and education are both safe and effective options for back pain. The next step is to establish ways to increase the size of their effect. Personalised exercise and education has promise over existing ‘one size fits all’ exercise and education. Two randomised controlled trials (RCTs) by my research group (One in Norway and one trial led by me for my PhD in University of Limerick (n=208)) demonstrate that when exercise and education is tailored to the physical, lifestyle and psychological profile of each individual with CLBP, clinical outcomes are superior to ‘one size fits all’ therapies. Personalised exercise and education, delivered by a single clinician, appears a promising option for CLBP. The objectives of COMPEL are: 1. To determine how personalised exercise and education reduces pain and disability in individuals with CLBP 2. To determine if there are individuals with CLBP who respond better or worse to personalised exercise and education 3. To investigate the cost-effectiveness of personalised exercise and education for CLBP 4. To disseminate and communicate results to the scientific community, clinicians, patients and policymakers The action found that changing pain self-efficacy accounts for most of the benefit from personalised care; people of a lower socioeconomic status and poorer health do not respond as well to personalised care; and personalised care is cost effective compared to group care.
Data: CORDIS, © European Union
Project objective
Back pain is the leading cause of disability in Europe. Chronic low back pain (CLBP) is the most costly and burdensome form. As the EU population ages, there is an urgent need for more clinically and cost-effective therapies to ensure sustainable healthcare. Dr O’Keeffe will explore a personalised medicine approach to exercise and education for CLBP. This is cutting edge, and has shown promising results beyond other therapies. Dr O’Keeffe is the perfect match for this project, as she has led a trial on this novel therapy for her PhD. This will be the first project to examine the mechanisms, response, and the cost-effectiveness of personalised exercise and education for CLBP. This will build on Dr O’Keeffe’s experience to expand and develop her skills in this area. Dr O’Keeffe will be trained in mediation, moderation and economic evaluation. She will gain additional research skills in new study designs, research software, physical activity measurement, gender analysis and public patient involvement. She will gain transferable skills in communication and public engagement, interdisciplinary networking, grantsmanship, project management, leadership and supervision. She will gain exposure to the non-academic sector through a secondment to a non-governmental organisation. Dr O’Keeffe will disseminate her results through open-access journals and conferences. She will communicate her results and Marie Sklodowska-Curie experience through social media, TV, radio and European Research events. If awarded this fellowship, Dr O’Keeffe will be equipped with the right skillset to improve her employability and reach a position of professional maturity. She will expand the European Research Area by strengthening networks. She will put Europe at the forefront of excellence and innovation for CLBP by promoting a safe exercise and education therapy for EU citizens. This will allow billions of euro that the EU currently spends on CLBP to be redirected to other health care services.
Original text from CORDIS.
Participants
Links
Data: CORDIS, © European Union